CMC/DHK Not Impacted by Contaminated Steroid Injection Medication
October 08, 2012
Cheshire Medical Center/Dartmouth-Hitchcock Keene is closely monitoring the situation involving tainted doses of the injectable steroid methylprednisolone acetate, distributed to health care providers in as many as 23 states and which is linked to outbreaks of meningitis.
Cheshire Medical Center/Dartmouth-Hitchcock Keene staff have confirmed that it has not received or administered the product in question from New England Compounding Center, the vendor believed to be the origin of the tainted steroid.
At Cheshire Medical Center/Dartmouth-Hitchcock Keene, patient safety is always our highest priority, and we will continue to monitor the situation. The New Hampshire Department of Health and Human Services (DHHS) is actively involved, working with healthcare institutions known to have administered the product in question. The Centers for Disease Control and Prevention also provides a number of resources for patients and providers on the outbreak.
As always, Cheshire Medical Center/Dartmouth-Hitchcock Keene urges its patients that have any questions or concerns about their health to please contact their provider.
Cheshire Medical Center/Dartmouth-Hitchcock Keene is a non-profit community hospital and clinic with a mission to lead our community to become the nation's healthiest through our clinical and service excellence, collaboration, and compassion for every patient, every time. Founded by CMC/D-HK, Vision 2020 is a community-wide health initiative designed to actively engage the citizens of Cheshire County in the process of becoming the nation's healthiest community by 2020. Learn more at cheshiremed.org.